BP’s Covetrus, Inc. Common Stock CVET Stock Holding History

BP’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,600	Closed	-$242K	–	496
2019 Q1	$242K	Buy	+7,600	New	+$270K	0.01%	382

Other funds holding CVET

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BP's CVET Position: Q2 2019 in Review

BP sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2019, closing a stake of 7,600 shares — an estimated $242K sold.

BP first reported a position in CVET in Q1 2019 and held it in 1 quarter. The position peaked at $242K in Q1 2019. 320 funds tracked by Wall St. Rank hold CVET as of Q2 2019.

BP reported no remaining Covetrus, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
BP sold 7,600 Covetrus, Inc. Common Stock shares in Q2 2019, an estimated $242K.
BP first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
BP's Covetrus, Inc. Common Stock position peaked at $242K in Q1 2019.
320 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2019.

Based on BP's 13F filing for Q2 2019, filed 29 Jul 2019.